THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

Context Capital Management, LLC's Holding History (CIK: 0001301396)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 31,463 Value ($000) $28,740 Avg Close — Range —
Q1 2022
Shares 25,735 Value ($000) $24,712 Avg Close — Range —
Q4 2021
Shares 25,076 Value ($000) $24,207 Avg Close — Range —
Q3 2021
Shares 25,388 Value ($000) $23,544 Avg Close — Range —
Q2 2021
Shares 19,838 Value ($000) $18,896 Avg Close — Range —
Q1 2021
Shares 9,473 Value ($000) $9,639 Avg Close — Range —
Q4 2020
Shares 13,473,000 Value ($000) $12,756 Avg Close — Range —
Q3 2020
Shares 7,250,000 Value ($000) $6,345 Avg Close — Range —
Q2 2020
Shares 1,750,000 Value ($000) $1,685 Avg Close — Range —
Q1 2020
Shares 3,500,000 Value ($000) $3,391 Avg Close — Range —
Q4 2019
Shares 7,500,000 Value ($000) $7,863 Avg Close — Range —
Q3 2019
Shares 6,000,000 Value ($000) $5,565 Avg Close — Range —
Q2 2019
Shares 6,000,000 Value ($000) $5,158 Avg Close — Range —
Q1 2019
Shares 6,000,000 Value ($000) $5,827 Avg Close — Range —
Q4 2018
Shares 6,500,000 Value ($000) $6,703 Avg Close — Range —
Q3 2018
Shares 6,500,000 Value ($000) $7,702 Avg Close — Range —
Q2 2018
Shares 5,500,000 Value ($000) $5,466 Avg Close — Range —
Q1 2018
Shares 3,500,000 Value ($000) $3,567 Avg Close — Range —
Q4 2017
Shares 3,500,000 Value ($000) $3,842 Avg Close — Range —
Q3 2017
Shares 3,500,000 Value ($000) $4,288 Avg Close — Range —
Q2 2017
Shares 3,500,000 Value ($000) $4,734 Avg Close — Range —
Q1 2017
Shares 2,500,000 Value ($000) $3,180 Avg Close — Range —
Q4 2016
Shares 1,500,000 Value ($000) $1,730 Avg Close — Range —